CLINICAL_TRIALS
trial_result
· 2025-07-29
Clinical Trial Update: SAPIEN 3 Ultra EU PMS
Summary
EU post-market surveillance study for the SAPIEN 3 Ultra transcatheter aortic valve has completed and posted results as of 2025-07-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Edwards Lifesciences | Conditions: Aortic Stenosis, Aortic Valve Stenosis | Status: COMPLETED | Results posted: 2025-07-29